Home › Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research
 

Keywords :   


Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research

2016-01-25 01:16:11| Biotech - Topix.net

The firm presently has a $2.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's target price indicates a potential upside of 4.04% from the stock's current price.

Tags: buy research investment upgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »